The Executive Leadership Committee is made up of individuals from various medical affairs backgrounds, whose mission it is to ensure the BCMAS program is always dynamic and innovative in accordance with the latest industry trends
MD
VP, Global Medical and Scientific Affairs at Ironwood Pharmaceuticals
M.D, Ph.D
Chief Medical Officer at Lexicon Pharmaceuticals
JD
Executive Vice President, Promotional Review & Labeling Services at ProPharma Group
PharmD, BCPS, MPH, BCMAS
Associate Director- Global Regulatory Affairs -US Advertising and Promotion at Eli Lilly & Company
PharmD, MBA, BCMAS
Vice President, Global Medical Strategic Operations at Gilead Sciences
PharmD, BCMAS
Clinical Professor and Chair, Pharmacy Practice at St. John's University
MD, MBA
Chief Medical Officer, Agile Therapeutics
MD, CMD
Vice President & Global Head of Medical Affairs
MD, MBA, MPH, BCMAS
Director, Global Medical Affairs
MD
Global Medical Affairs Lead - Early Drug Development, Immunology at GSK
MD
Medical Doctor, Pharmaceutical Leader
PharmD, BCMAS
Associate Regional Medical Director at AbbVie
PharmD
Sr. Director, Scientific Communications and Operations
PhD, BCMAS
Vice President, Global Head of Medical Affairs at Thermo Fisher Scientific
PhD, RPh, BCMAS
Medical Science Liaison Director at Novartis Pharmaceuticals
PACS, CPPM
Associate Director, Field Reimbursement at Tarsus Pharmaceuticals, Inc
PharmD, RPh, MBA, BCMAS
Director, North America Strategic Engagement Medical Affairs at Regeneron
Vice President - Field Access & Reimbursement at Inizio Engage
PharmD
Medical Communications and Content Solutions, Team Lead at Pfizer